| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 34 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2020 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sell | 20,000 | $60.11 | $1,202,200.60 | -1.7% | |
| Jan 6, 2020 | Given Bruce D | Chief Operating Officer | Sell | 35,613 | $60.13 | $2,141,285.21 | -1.4% | |
| Dec 24, 2019 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 83,333 | $63.50 | $5,291,645.50 | -4.4% | |
| Dec 13, 2019 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 183,333 | $67.15 | $12,310,119.07 | -1.2% | |
| Dec 3, 2019 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 50,000 | $67.33 | $3,366,521.82 | -0.3% | |
| Nov 1, 2019 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sale+OE | 37,884 | $40.85 | $1,547,378.04 | -5.6% | |
| Oct 10, 2019 | Anzalone Christopher Richard60 | Chief Executive Officer | Sale+OE | 56,325 | $31.83 | $1,792,824.75 | -2.6% | |
| Sep 25, 2019 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 20,000 | $28.25 | $565,000.00 | -0.9% | |
| Sep 24, 2019 | Anzalone Christopher Richard60 | Chief Executive Officer | Sale+OE | 112,650 | $28.54 | $3,215,055.12 | -1.3% | |
| Sep 11, 2019 | Perry Michael S55 | Director | Sell | 185,000 | $29.41 | $5,440,000.00 | -54.1% |